{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:17Z","timestamp":1790356037691,"version":"4.1.0"},"reference-count":87,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pandemics threaten economies, security, and public health, requiring strong global and local collaboration and coordination. Public receptivity to emergent vaccine technologies is essential to pandemic readiness. Although messenger RNA (mRNA) vaccines offer rapid adaptability and hold promise, their use during the COVID-19 pandemic was met with polarizing debates that raise questions about the conditions needed to support acceptable and equitable use of new vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This deliberative dialogue study aims to generate consensus on how to ensure informed, accessible public engagement and strengthen public trust in a climate of divisiveness and misinformation, disinformation, and malinformation. Using mRNA vaccines as a case study, the project\u2019s specific research objective is to seek insights into what people believe is needed for public understanding, equitable access, and acceptance of emerging vaccine technologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a sequential deliberative dialogue design, this study invites individuals with significant influence on pandemic readiness and those most likely to be disproportionately affected by related decisions into reflective, conversational, workshop-style online events and self-led dialogues. Dialogues and guiding questions are informed by a knowledge synthesis on what is unknown about mRNA vaccine public sentiments based on a rapid review, an environmental scan, consultations with experts across sectors, and ongoing updates from the dialogues. Data will be analyzed in situ in an iterative and collaborative synthesis of general agreements between dialogue contributors in response to guiding questions and emerging themes. Dialogue reports will be drafted by the research team based on observational notes, transcripts, and video recordings and reviewed by contributors. In summative dialogues, the research team will present main threads of dialogue, responding to research objectives and newly identified knowledge gaps and collecting input to inform dialogue outputs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study was funded in May 2025. As of June 2026, we have conducted 10 deliberative dialogues and supported 1 self-led dialogue, engaging 77 contributors across sectors and disciplines. We held 2 summative dialogues with 18 attendees, where we presented the main threads of dialogue as identified by the research team through collaborative analysis. We have started incorporating input from closing dialogues into the final reports and expect to publish the results in the second half of 2026, both as lay-language reports and peer-reviewed manuscripts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This protocol outlines a consensus-building process capable of deepening the understanding of vaccine hesitancy and strengthening pandemic readiness and public trust in Canada. Dialogues are expected to provide general agreements on how to enhance science and health literacy, tailor communications considering historical inequities, respond to the needs of health care workers, and navigate polarization around vaccination. By creating space for shared learning and collective insight, this study supports the rebuilding of trust in public health institutions as they adapt to evolving societal expectations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/91534","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:25:08Z","timestamp":1783718708000},"page":"e91534-e91534","source":"Crossref","is-referenced-by-count":0,"title":["Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-0621","authenticated-orcid":false,"given":"Katrina","family":"Plamondon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-6589","authenticated-orcid":false,"given":"Rodrigo","family":"Curty Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-2796","authenticated-orcid":false,"given":"Angeli","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"7","key":"R1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179519","article-title":"Pandemics past, present, and future: progress and persistent risks","volume":"134","author":"Casadevall","journal-title":"J Clin Invest"},{"issue":"10","key":"R2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038695","article-title":"The 1918 influenza pandemic and its legacy","volume":"10","author":"Taubenberger","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"R3","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S2666-5247(20)30088-4","article-title":"Towards pandemic preparedness beyond COVID-19","volume":"1","author":"Naguib","journal-title":"Lancet Microbe"},{"issue":"9","key":"R4","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1016\/S2468-2667(22)00192-X","article-title":"An effective pandemic treaty requires accountability","volume":"7","author":"Faviero","journal-title":"Lancet Public Health"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"2457239","DOI":"10.1080\/23288604.2025.2457239","article-title":"Rethinking trust and public health compliance: introducing a trust continuum for policy and practice","volume":"11","author":"Fox","journal-title":"Health Syst Reform"},{"key":"R6","unstructured":"WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. World Health Organization; 2020. URL: https:\/\/www.nitag-resource.org\/sites\/default\/files\/2020-09\/WHO-2019-nCoV-SAGE_Framework-Allocation_and_prioritization-2020.1-eng.pdf [Accessed 04-02-2026]"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Nickerson JW Herder M . COVID-19 vaccines as global public goods. In: Flood CM MacDonnell V Philpott J Theriault S Venkatapuran S , editors. Vulnerable: The Law, Policy and Ethics of COVID-19. University of Ottawa Press; 2020:591-600. [doi: 10.2307\/jj.22247013.48]","DOI":"10.2307\/jj.22247013.48"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Hoang V . Optimal allocation mechanism for scarce public goods: a cross-country analysis and key lessons from covid-19 vaccines. Preprints.org. Preprint posted online on May 18, 2023. [doi: 10.20944\/preprints202305.1279.v1]","DOI":"10.20944\/preprints202305.1279.v1"},{"issue":"6509","key":"R9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.abe2803","article-title":"An ethical framework for global vaccine allocation","volume":"369","author":"Emanuel","journal-title":"Science"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01678-5","article-title":"Vaccine equity in low and middle income countries: a systematic review and meta-analysis","volume":"21","author":"Ali","journal-title":"Int J Equity Health"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1429265","article-title":"Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19","volume":"12","author":"Iqbal","journal-title":"Front Public Health"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01019-3","article-title":"Mapping global public perspectives on mRNA vaccines and therapeutics","volume":"9","author":"Xu","journal-title":"NPJ Vaccines"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","journal-title":"J Control Release"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","journal-title":"Annu Rev Med"},{"issue":"6","key":"R15","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"Park","journal-title":"Int J Biol Sci"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Drahos P . Public lies and public goods: ten lessons from when patents and pandemics meet. In: Ghidini G Falce V , editors. Reforming Intellectual Property. Edward Elgar Publishing; 2022:30-44. [doi: 10.4337\/9781803922256.00008] ISBN: 9781803922249","DOI":"10.4337\/9781803922256.00008"},{"key":"R17","unstructured":"Bostrom A Nayyar S . The summit of the future: health technologies for the common good. United Nations; 2024. URL: https:\/\/sdgs.un.org\/sites\/default\/files\/2024-05\/Bostrom%3B%20Nayyar_The%20Summit%20of%20the%20Future.pdf [Accessed 05-02-2026]"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1017\/S147474562400020X","article-title":"mRNA technology transfer hub and intellectual property: towards a more equitable and sustainable model","volume":"24","author":"Adekola","journal-title":"World Trade Rev"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"2425121","DOI":"10.1080\/23299460.2024.2425121","article-title":"mRNA vaccine politics: responsible governance coordination for vaccine innovation in times of urgency","volume":"11","author":"Sideri","journal-title":"J Responsible Innov"},{"issue":"2","key":"R20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/vaccines13020112","article-title":"Investment opportunities for mRNA technology in low- and middle-income countries: key findings and future perspectives","volume":"13","author":"Abreu","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"R21","first-page":"145","volume":"31","author":"Joseph","journal-title":"J Transnat Law Policy"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2024.2335360","article-title":"Pandemics, intellectual property and 'our economy': a worldview analysis of Canada's role in compromising global access to COVID-19 vaccines","volume":"19","author":"Brisbois","journal-title":"Glob Public Health"},{"issue":"7","key":"R23","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s11606-021-06698-5","article-title":"No populations left behind: vaccine hesitancy and equitable diffusion of effective COVID-19 vaccines","volume":"36","author":"Webb Hooper","journal-title":"J Gen Intern Med"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1950504","article-title":"COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety","volume":"18","author":"Kricorian","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","DOI":"10.1186\/s13037-021-00291-9","article-title":"Review the safety of Covid-19 mRNA vaccines: a review","volume":"15","author":"Anand","journal-title":"Patient Saf Surg"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/poms.13916","article-title":"Implications of vaccine shopping during pandemic","volume":"32","author":"Nageswaran","journal-title":"Prod Oper Manag"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.756623","article-title":"The waiver of patent protections for COVID-19 vaccines during the ongoing pandemic and the conspiracy theories: lights and shadows of an issue on the ground","volume":"8","author":"Nioi","journal-title":"Front Med (Lausanne)"},{"key":"R28","unstructured":"Labont\u00e9 R Johri M . Canada\u2019s opposition to a WTO proposal hurts developing countries\u2019 pandemic fight. The Globe and Mail. 2020. URL: https:\/\/www.theglobeandmail.com\/opinion\/article-canadas-opposition-to-a-wto-proposal-hurts-developing-countries\/ [Accessed 05-02-2026]"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/10755470221129608","article-title":"Benefits and pitfalls of debunking interventions to counter mRNA vaccination misinformation during the COVID-19 pandemic","volume":"44","author":"Schmid","journal-title":"Sci Commun"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.56098\/ijvtpr.v2i1.23","article-title":"Worse than the disease? Reviewing some possible unintended consequences of the mRNA vaccines against COVID-19","volume":"2","author":"Seneff","journal-title":"Vaccine Theory Prac Res"},{"issue":"5","key":"R31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251605","article-title":"COVID-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence","volume":"16","author":"Islam","journal-title":"PLoS One"},{"issue":"2","key":"R32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47368\/ejhc.2022.201","article-title":"Addressing COVID-19 vaccination conspiracy theories and vaccination intentions","volume":"3","author":"Pummerer","journal-title":"Eur J Health Commun"},{"issue":"2","key":"R33","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13778","article-title":"Conspiracy theories in the era of COVID-19: a tale of two pandemics","volume":"75","author":"Stein","journal-title":"Int J Clin Pract"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11196-022-09910-9","article-title":"Rise of conspiracy theories in the pandemic times","volume":"35","author":"Ku\u017celewska","journal-title":"Int J Semiot Law"},{"issue":"9","key":"R35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10453","article-title":"Role of mass media and public health communications in the COVID-19 pandemic","volume":"12","author":"Anwar","journal-title":"Cureus"},{"issue":"4","key":"R36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1057\/s41271-020-00247-w","article-title":"Leveraging media and health communication strategies to overcome the COVID-19 infodemic","volume":"41","author":"Mheidly","journal-title":"J Public Health Policy"},{"issue":"6-7","key":"R37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/0275074020941734","article-title":"A failure of political communication not a failure of bureaucracy: the danger of presidential misinformation during the COVID-19 pandemic","volume":"50","author":"Hatcher","journal-title":"Am Rev Public Adm"},{"issue":"4","key":"R38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/wmh3.363","article-title":"An analysis of government communication in the United States during the COVID-19 pandemic: recommendations for effective government health risk communication","volume":"12","author":"Kim","journal-title":"World Med Health Policy"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/hs.2020.0190","article-title":"A failure to communicate? How public messaging has strained the COVID-19 response in the United States","volume":"19","author":"Sauer","journal-title":"Health Secur"},{"issue":"Suppl 1","key":"R40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.17269\/s41997-022-00702-z","article-title":"Public health communication in Canada during the COVID-19 pandemic","volume":"113","author":"Lowe","journal-title":"Can J Public Health"},{"key":"R41","unstructured":"Lutter R . CDC\u2019s covid-19 communication failures: reforming the process for public health recommendations. Manhattan Institute; 2022. URL: https:\/\/media4.manhattan-institute.org\/sites\/default\/files\/cdc-covid-19-communication-failures_0.pdf [Accessed 05-02-2026]"},{"issue":"12","key":"R42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32437","article-title":"A survey of public health failures during COVID-19","volume":"14","author":"Dominquez","journal-title":"Cureus"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2020.100012","article-title":"Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications","volume":"1","author":"Paul","journal-title":"Lancet Reg Health Eur"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.2196\/56931","article-title":"A comprehensive analysis of COVID-19 misinformation, public health impacts, and communication strategies: scoping review","volume":"26","author":"Kisa","journal-title":"J Med Internet Res"},{"issue":"2","key":"R45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vacun.2021.01.001","article-title":"Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals","volume":"22","author":"Ullah","journal-title":"Vacunas"},{"key":"R46","unstructured":"The sustainable development goals report 2020. United Nations, Department of Economic and Social Affairs (UN DESA); 2020. URL: https:\/\/unstats.un.org\/sdgs\/report\/2020\/The-Sustainable-Development-Goals-Report-2020.pdf [Accessed 05-02-2026]"},{"issue":"1","key":"R47","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1080\/07853890.2021.2009128","article-title":"Impact of COVID-19 pandemic on routine immunization","volume":"53","author":"Ota","journal-title":"Ann Med"},{"issue":"2","key":"R48","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2219577","article-title":"Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present","volume":"19","author":"Hamson","journal-title":"Hum Vaccin Immunother"},{"issue":"23","key":"R49","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192316266","article-title":"The Impact of COVID-19 on the Sustainable Development Goals: achievements and expectations","volume":"19","author":"Mart\u00edn-Blanco","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"R50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88196","article-title":"The 2025 United States measles crisis: when vaccine hesitancy meets reality","volume":"17","author":"Adeoye","journal-title":"Cureus"},{"issue":"9","key":"R51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1542\/pir.2022-005921","article-title":"Measles update in an era of vaccine hesitancy and global pandemic","volume":"44","author":"Flores","journal-title":"Pediatr Rev"},{"issue":"4","key":"R52","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2214-109X(23)00063-3","article-title":"Exacerbation of measles mortality by vaccine hesitancy worldwide","volume":"11","author":"Pandey","journal-title":"Lancet Glob Health"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103047","article-title":"Mpox vaccination hesitancy, previous immunisation coverage, and vaccination readiness in the African region: a multinational survey","volume":"80","author":"Du","journal-title":"EClinicalMedicine"},{"issue":"2","key":"R54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.56936\/18290825-2.v19.2025-4","article-title":"Intersecting pandemics: analyzing the relationship between mpox and COVID-19","volume":"19","author":"Mohammad","journal-title":"New Armenian Med J"},{"issue":"1","key":"R55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/00027162221084709","article-title":"Defining and measuring scientific misinformation","volume":"700","author":"Southwell","journal-title":"Ann Am Acad Pol Soc Sci"},{"issue":"2","key":"R56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0267323118760317","article-title":"The disinformation order: disruptive communication and the decline of democratic institutions","volume":"33","author":"Bennett","journal-title":"Eur J Commun"},{"issue":"1","key":"R57","doi-asserted-by":"publisher","DOI":"10.2196\/45731","article-title":"Defining misinformation and related terms in health-related literature: scoping review","volume":"25","author":"El Mikati","journal-title":"J Med Internet Res"},{"key":"R58","doi-asserted-by":"crossref","unstructured":"Plamondon KM Hatfield J . Using Dialogue-Based Methods to Create Normative Principles for Global Health Research. SAGE Publications Ltd; 2017. [doi: 10.4135\/9781526423368]","DOI":"10.4135\/9781526423368"},{"key":"R59","doi-asserted-by":"crossref","unstructured":"Graham ID Rycroft-Malone J Kothari A McCutcheon C , editors. Research Co\u2010Production in Healthcare. John Wiley & Sons; 2022. ISBN: 978-1-119-75725-2","DOI":"10.1002\/9781119757269"},{"key":"R60","doi-asserted-by":"crossref","unstructured":"Plamondon K Ndumbe-Eyoh S Shahram S . Equity, power, and transformative research coproduction. In: Graham ID Rycroft-Malone J Kothari A McCutcheon C , editors. Research Coproduction in Healthcare. John Wiley & Sons; 2022:34-53. [doi: 10.1002\/9781119757269]","DOI":"10.1002\/9781119757269.ch3"},{"issue":"1","key":"R61","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.ssmhs.2024.100010","article-title":"Actioning the learning health system: an applied framework for integrating research into health systems","volume":"2","author":"Reid","journal-title":"SSM Health Syst"},{"issue":"1","key":"R62","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-019-1108-x","article-title":"Connecting knowledge with action for health equity: a critical interpretive synthesis of promising practices","volume":"18","author":"Plamondon","journal-title":"Int J Equity Health"},{"key":"R63","unstructured":"Freire P . Pedagogy of the Oppressed. Continuum; 1997. ISBN: 978-0-8264-1276-8"},{"issue":"3","key":"R64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/002205748716900303","article-title":"What is the \u201cDialogical Method\u201d of teaching?","volume":"169","author":"Shor","journal-title":"J Educ"},{"issue":"11","key":"R65","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1177\/1049732315581603","article-title":"Analyzing data generated through deliberative dialogue: bringing knowledge translation into qualitative analysis","volume":"25","author":"Plamondon","journal-title":"Qual Health Res"},{"issue":"11","key":"R66","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.socscimed.2012.06.016","article-title":"Deliberative dialogues as a mechanism for knowledge translation and exchange in health systems decision-making","volume":"75","author":"Boyko","journal-title":"Soc Sci Med"},{"issue":"4","key":"R67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.0020-2754.1997.00505.x","article-title":"Evaluating qualitative research in social geography: establishing 'rigour' in interview analysis","volume":"22","author":"Baxter","journal-title":"Trans Inst Br Geogr"},{"key":"R68","unstructured":"Plamondon K Shahram SZ . How to Equity in Inviting Participation. The Equity Science Lab, University of British Columbia; 2024:38. URL: https:\/\/open.library.ubc.ca\/soa\/cIRcle\/collections\/facultyresearchandpublications\/52383\/items\/1.0440707 [Accessed 06-08-2026]"},{"issue":"13","key":"R69","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","journal-title":"Qual Health Res"},{"issue":"1","key":"R70","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2023-000444","article-title":"Workplace violence in the COVID-19 era: a qualitative analysis of harassment and threats against public health professionals in Canada","volume":"1","author":"Regehr","journal-title":"BMJ Public Health"},{"issue":"5","key":"R71","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2105\/AJPH.2021.306649","article-title":"Pandemic-related workplace violence and its impact on public health officials, March 2020\u2012January 2021","volume":"112","author":"Ward","journal-title":"Am J Public Health"},{"issue":"1","key":"R72","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13865","article-title":"Relational practices for meaningful inclusion in health research: results of a deliberative dialogue study","volume":"27","author":"Plamondon","journal-title":"Health Expect"},{"key":"R73","unstructured":"Chatham house rule. Chatham House. 2014. URL: https:\/\/www.chathamhouse.org\/about-us\/chatham-house-rule [Accessed 05-02-2026]"},{"issue":"1","key":"R74","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1177\/160940691301200137","article-title":"Beyond words: using nonverbal communication data in research to enhance thick description and interpretation","volume":"12","author":"Denham","journal-title":"Int J Qual Methods"},{"issue":"1","key":"R75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1743727X.2014.914487","article-title":"Beyond member-checking: a dialogic approach to the research interview","volume":"38","author":"Harvey","journal-title":"Int J Res Method Educ"},{"issue":"6","key":"R76","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/cts.13273","article-title":"Considerations for addressing anti-vaccination campaigns: how did we get here and what can we do about it?","volume":"15","author":"Barrett","journal-title":"Clin Transl Sci"},{"issue":"3","key":"R77","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1037\/xap0000464","article-title":"Reducing vaccine hesitancy by explaining vaccine science","volume":"29","author":"Joslyn","journal-title":"J Exp Psychol Appl"},{"key":"R78","unstructured":"Song M Blake-Hepburn D Roerig M Sharma T Pawa J Allin S . Community partnerships and COVID-19 vaccines. North American Observatory on Health Systems and Policies; 2023. URL: https:\/\/naohealthobservatory.ca\/wp-content\/uploads\/2023\/07\/NAO-Rapid-Review-41_EN.pdf [Accessed 25-07-2026]"},{"issue":"Suppl 1","key":"R79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.17269\/s41997-022-00699-5","article-title":"Public health community engagement with Asian populations in British Columbia during COVID-19: towards a culture-centered approach","volume":"113","author":"Pringle","journal-title":"Can J Public Health"},{"issue":"1","key":"R80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15534510.2022.2116105","article-title":"Perceived longevity of mRNA technology increases support for Covid-19 vaccines","volume":"17","author":"Eidelman","journal-title":"Soc Influ"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2025.1607727","article-title":"What lessons can be learned from the management of the COVID-19 pandemic?","volume":"70","author":"Quinn","journal-title":"Int J Public Health"},{"issue":"2","key":"R82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/medhum-2022-012501","article-title":"Where past meets present: indigenous vaccine hesitancy in Saskatchewan","volume":"49","author":"Sullivan","journal-title":"Med Humanit"},{"issue":"1","key":"R83","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2024.2384497","article-title":"Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review","volume":"17","author":"Tinessia","journal-title":"Glob Health Action"},{"issue":"9","key":"R84","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ajic.2021.04.079","article-title":"Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: a multicenter survey","volume":"49","author":"Dzieciolowska","journal-title":"Am J Infect Control"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1016\/j.techfore.2024.123384","article-title":"Why should innovators care about morality? Political ideology, moral foundations, and the acceptance of technological innovations","volume":"203","author":"Claudy","journal-title":"Technol Forecast Soc Change"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.900386","article-title":"Social media news use induces COVID-19 vaccine hesitancy through skepticism regarding its efficacy: a longitudinal study from the United States","volume":"13","author":"Ahmed","journal-title":"Front Psychol"},{"key":"R87","unstructured":"Equity Science Lab. URL: https:\/\/equityscience.ca [Accessed 25-07-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:42:17Z","timestamp":1790354537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e91534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":87,"URL":"https:\/\/doi.org\/10.2196\/91534","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"v15i7e91534"}}